Mikkelsen, S. U., Kjær, L., Bjørn, M. E., Knudsen, T. A., Sørensen, A. L., Andersen, C. B. L., . . . Hasselbalch, H. C. (2018). Safety and efficacy of combination therapy of interferon‐α2 and ruxolitinib in polycythemia vera and myelofibrosis. Cancer Med.
Chicago ZitierstilMikkelsen, Stine Ulrik, et al. "Safety and Efficacy of Combination Therapy of Interferon‐α2 and Ruxolitinib in Polycythemia Vera and Myelofibrosis." Cancer Med 2018.
MLA ZitierstilMikkelsen, Stine Ulrik, et al. "Safety and Efficacy of Combination Therapy of Interferon‐α2 and Ruxolitinib in Polycythemia Vera and Myelofibrosis." Cancer Med 2018.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.